May 02, 2017

Belluck & Fox Wins Another Appeals Court Ruling on Behalf of Mesothelioma Victims
-- Mesothelioma law firm Belluck & Fox is proud to announce that it has won an appeal on behalf of its clients Nicholas and Lorraine Dominick regarding Mr. Dominick's case, proving Belluck & Fox is a top-rated law firm in the USA. --

    NEW YORK, NY, May 02, 2017 /24-7PressRelease/ -- New York Mesothelioma law firm Belluck & Fox is proud to announce that it has won an appeal on behalf of its clients Nicholas and Lorraine Dominick regarding Mr. Dominick's development of mesothelioma, affirming the jury verdict against defendant Charles Millar & Son, and its successor in interest, Pacemaker Steel & Piping Co. This decision again shows that Belluck & Fox, LLP is a top-rated mesothelioma law firm in New York and across the country. Belluck & Fox, LLP has the lawyers and resources to take cases all the way to verdict and to defend those verdicts on appeal

Nicholas Dominick worked as an internal grinder at the Chicago Pneumatic tool manufacturing plant from 1968 to 1973. During the course of his employment, he was exposed to asbestos from products supplied by Pacemaker's predecessor to the plant. In 2015, a jury concluded that Pacemaker was 30% liable for causing Mr. Dominick's mesothelioma. The jury awarded the Dominicks a total of $4 million dollars: $1 million for past pain and suffering, and $3 million for future pain and suffering in Dominick, et al. v. A.O. Smith Water Products Co., et al., No. CA2014-000232 (N.Y. Sup. Ct., Oneida Cty.).

In March 2016, Pacemaker asked the trial judge, the Honorable Charles C. Merrell of the New York Supreme Court, to overturn the jury verdict and dismiss the case. Belluck & Fox successfully defeated that motion, and Charles Millar appealed. On April 28th, 2017, the Appellate Division, Fourth Judicial Department, affirmed the jury verdict against Pacemaker in all respects. This ruling is not only a victory for the Dominicks, but it is also a substantial victory for asbestos victims everywhere who are seeking relief and damages for their illnesses.

In its ruling, the Appellate Court again substantively rejected each claim that Pacemaker offered, most importantly with regards to specific causation and monetary damages. The Court concluded that "Contrary to the Millar defendants' contention, the expert's opinion, considered along with the rest of her testimony, was sufficient to establish specific causation." This ruling helps to confirm that the theory of causation advanced by the experts called on behalf of asbestos victims is valid under New York law. The Court also refused to reduce the award of future damages for pain and suffering, concluding that $3 million for one year of future pain and suffering was reasonable.

Partner Seth Dymond of Belluck & Fox represented the plaintiff-respondents in this action. George F. Carpinello of Boies, Schiller & Flexner LLP represented the defendants.

About Belluck & Fox
The New York mesothelioma law firm of Belluck & Fox, LLP, represents victims of mesothelioma and other asbestos-related diseases, as well as individuals with claims related to other mass torts, motorcycle crashes, lead paint and other serious injuries. The firm's attorneys have won more than $800 million in compensation for clients and their families. The firm's headquarters is located at 546 Fifth Avenue, Fourth Floor, New York, NY 10036 (local phone 212-681-1575). The firm also features New York offices in Clifton Park, Rochester and Woodstock. For more information, contact the firm through its online form or call 877-MESOTHELIOMA (877-637-6843).

# # #

Contact Information:
Joseph DiCastro
Belluck & Fox, LLP
New York, NY
United States
Voice: (212) 681-1575

If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Use disclaimer for more information.
This News Release can be viewed online at: